These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 26714930

  • 1. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway.
    Wu F, Chen WJ, Yan L, Tan GQ, Li WT, Zhu XJ, Ge XC, Liu JW, Wang BL.
    Cancer Med; 2016 Feb; 5(2):370-85. PubMed ID: 26714930
    [Abstract] [Full Text] [Related]

  • 2. Mus81 knockdown sensitizes colon cancer cells to chemotherapeutic drugs by activating CHK1 pathway.
    Wu F, Su SC, Tan GQ, Yan L, Li TY, Zhang HL, Yu JS, Wang BL.
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):592-601. PubMed ID: 28291626
    [Abstract] [Full Text] [Related]

  • 3. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P, Chen L, Li LH, Wei ZF, Tong B, Jia YG, Kong LY, Xia YF, Dai Y.
    BMC Cancer; 2014 Dec 19; 14():987. PubMed ID: 25527123
    [Abstract] [Full Text] [Related]

  • 4. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.
    Tu YS, Kang XL, Zhou JG, Lv XF, Tang YB, Guan YY.
    Eur J Pharmacol; 2011 Nov 30; 670(2-3):356-64. PubMed ID: 21958871
    [Abstract] [Full Text] [Related]

  • 5. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
    Duan L, Perez RE, Hansen M, Gitelis S, Maki CG.
    Cancer Biol Ther; 2014 Nov 30; 15(12):1600-12. PubMed ID: 25482935
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y, Ren KH, He HW, Shao RG.
    Cancer Biol Ther; 2009 Aug 30; 8(16):1559-66. PubMed ID: 19502782
    [Abstract] [Full Text] [Related]

  • 7. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo.
    Kang X, Wang F, Lan X, Li X, Zheng S, Lv Z, Zhuang Y, Zhao Y, Zhou S.
    Int J Med Sci; 2018 Aug 30; 15(1):69-76. PubMed ID: 29333089
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H, Yang Z, Liu C, Huang S, Wang H, Chen Y, Chen G.
    Biochem Biophys Res Commun; 2014 Nov 07; 454(1):71-7. PubMed ID: 25445601
    [Abstract] [Full Text] [Related]

  • 10. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J, Zhu Z, Li W, Shen M, Cao C, Sun Q, Guo Z, Liu L, Wu D.
    J Exp Clin Cancer Res; 2020 Oct 21; 39(1):222. PubMed ID: 33087136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
    Zheng L, Liang P, Li J, Huang XB, Liu SC, Zhao HZ, Han KQ, Wang Z.
    PLoS One; 2012 Oct 21; 7(9):e45412. PubMed ID: 23049798
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
    Ji DG, Guan LY, Luo X, Ma F, Yang B, Liu HY.
    Biochem Biophys Res Commun; 2018 Jun 18; 501(1):33-40. PubMed ID: 29702091
    [Abstract] [Full Text] [Related]

  • 14. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H, Chen F, Zhang L, Zhou Q, Gui S, Wang Y.
    Oncol Rep; 2016 Jul 18; 36(1):333-41. PubMed ID: 27177208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.
    Yu YS, Tang ZH, Pan QC, Chen XH, Liu XN, Zang GQ.
    Cancer Chemother Pharmacol; 2012 May 18; 69(5):1173-80. PubMed ID: 22237956
    [Abstract] [Full Text] [Related]

  • 18. Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin.
    Ma JL, Zeng S, Zhang Y, Deng GL, Shen H.
    Tumour Biol; 2016 May 18; 37(5):6177-84. PubMed ID: 26614432
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells.
    Yuan Z, Guo W, Yang J, Li L, Wang M, Lei Y, Wan Y, Zhao X, Luo N, Cheng P, Liu X, Nie C, Peng Y, Tong A, Wei Y.
    J Biol Chem; 2015 Jun 12; 290(24):14927-44. PubMed ID: 25918161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.